Related Experiment Video
Updated: Mar 7, 2026

03:20
Studying Chronic Exposure of Mice to Ultraviolet B Radiation
Published on: August 19, 2025
2.1K
A Clinical Trial of "B-663" in Vitiligo
Indian Journal of Dermatology, Venereology and Leprology
|February 21, 2017
Abstract:
'B663' (3-P chloranilino) - 10 (P-Chlorophenyl) - 2, 10-dihydro-2-(ISO-prophylimino) (lampre-ne, Hansepran) was tried in 20 pmknts with vitiligo. Majority of cam (I 7) did not show any improvement Three cases showed slight repigmentation. Generalised dark brown pigmentation was a major deterrent for the patients to use this drug. Good results claimed in a previous report, could not be substantiated by us.

